Abstract
5-Fluorouracil (5-FU) is routinely used in the treatment of gastrointestinal, breast and head and neck cancers. A major limitation to the use of this drug is acquired or inherent resistance.
Original language | English |
---|---|
Pages (from-to) | 417-23 |
Number of pages | 7 |
Journal | Anticancer Research |
Volume | 24 |
Issue number | 2A |
Publication status | Published - 2004 |